TransMedics Group, Inc. logo TMDX - TransMedics Group, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 9
HOLD 3
SELL 0
STRONG
SELL
0
| PRICE TARGET: $122.67 DETAILS
HIGH: $142.00
LOW: $75.00
MEDIAN: $129.50
CONSENSUS: $122.67
UPSIDE: 76.07%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue
Revenue 605.5 441.5 241.6 93.5 30.3 25.6 23.6 13.0 7.7 6.2
Cost of Revenue 242.7 179.5 87.5 28.2 9.1 9.0 9.7 7.3 5.5 5.4
Gross Profit 362.8 262.1 154.1 65.3 21.2 16.6 13.9 5.7 2.1 0.8
Operating Expenses
R&D Expenses 69.1 56.0 63.3 26.8 22.3 18.8 19.9 13.7 15.0 15.6
SG&A Expenses 185.2 168.6 119.6 69.9 38.3 24.2 23.6 12.3 7.6 8.1
Other Expenses 0 0 0 0 0 0 0 (0.2) 0 0.0
Operating Expenses 254.2 224.6 182.8 96.7 60.6 43.0 43.5 26.0 22.6 23.8
Operating Income
Operating Income 108.6 37.5 (28.7) (31.4) (39.4) (26.4) (29.6) (20.2) (20.4) (23.0)
Interest Expense 13.8 14.4 10.8 3.7 3.9 4.0 4.4 2.4 1.1 1.0
Interest Income 0 0 12.5 0.9 0 1.7 0.8 0 0.5 0.0
Profitability
EBITDA 148.5 69.9 (7.7) (29.0) (38.5) (23.2) (27.9) (20.2) (19.1) (22.7)
EBIT 121.3 50.2 (15.9) (32.4) (40.3) (24.7) (29.2) (21.0) (19.7) (23.1)
Income Before Tax 107.5 35.8 (26.7) (36.2) (44.2) (28.7) (33.5) (23.7) (20.8) (24.1)
Income Tax Expense (82.8) 0.3 (1.6) 0.1 0.0 0.0 0.0 0.0 0.0 0
Net Income 190.3 35.5 (25.0) (36.2) (44.2) (28.7) (33.5) (23.8) (20.8) (24.1)
Per Share Data
EPS (Basic) 5.60 1.07 -0.77 -1.23 -1.60 -1.16 -2.36 -1.23 -1.44 -1.66
EPS (Diluted) 4.87 1.01 -0.77 -1.23 -1.60 -1.16 -2.36 -1.23 -1.44 -1.66
Shares Outstanding 34.0 33.2 32.5 29.6 27.6 24.7 14.2 19.2 14.5 14.5
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Current Assets
Cash & Cash Equivalents 488.4 336.6 394.8 201.2 25.6 24.6 20.1 20.2 11.9 9.8
Short-Term Investments 0 0 0 0 66.9 101.1 60.6 0 12.7 38.0
Net Receivables 84.3 97.7 63.6 27.6 5.9 6.9 6.6 3.4 0.9 1.4
Inventory 48.9 46.6 44.2 20.6 14.9 11.9 11.2 9.3 8.0 6.3
Other Current Assets 16.3 16.3 8.0 2.9 5.5 2.3 1.5 0 0 0
Total Current Assets 637.8 497.2 510.7 252.3 118.7 146.8 100.0 34.8 34.0 55.9
Non-Current Assets
Property, Plant & Equipment 332.8 292.5 180.5 24.4 15.7 4.8 4.8 3.5 2.5 1.7
Goodwill 11.5 11.5 12.0 0 0 0 0 0 0 0
Intangible Assets 1.9 2.2 2.4 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0.5 0.5 0 0.5 0.5 0.5 0
Other Non-Current Assets 0.7 0.7 0.6 0 0 0.5 0.0 3.4 0.0 0.5
Total Non-Current Assets 430.6 306.9 195.4 24.9 16.2 5.3 5.3 7.4 3.0 2.2
Total Assets 1,068.4 804.1 706.0 277.1 134.9 152.0 105.3 42.2 37.0 58.1
Current Liabilities
Account Payables 10.3 10.3 12.7 3.3 6.7 1.2 7.2 4.7 3.5 4.2
Short-Term Debt 13.3 2.7 0 0 0 0 0 0 1.8 0
Deferred Revenue 2.9 1.7 2.0 0.2 0.2 0.3 0.2 0.3 0.2 0
Other Current Liabilities 62.7 45.2 17.9 8.8 11.2 6.4 0.4 0.7 0.6 0.5
Total Current Liabilities 89.3 59.9 54.9 23.7 23.2 11.9 16.1 12.6 10.9 9.5
Non-Current Liabilities
Long-Term Debt 456.4 509.3 506.2 58.7 35.2 34.7 34.1 33.7 6.8 8.4
Deferred Tax Liabilities 0 0 0 0 0 0 0 (0.8) (1.1) 0
Other Non-Current Liabilities 49.6 0 0 0 0 1.6 0.4 0.8 188.0 1.4
Total Non-Current Liabilities 506.0 515.6 513.9 66.1 43.8 36.3 34.5 34.4 194.8 9.8
Total Liabilities 595.3 575.5 568.8 89.8 67.0 48.1 50.6 47.0 205.7 19.3
Stockholders' Equity
Common Stock 750.9 697.2 641.1 666.3 510.5 502.2 424.1 331.2 0.0 0.0
Retained Earnings (277.9) (468.2) (503.7) (478.7) (442.4) (398.2) (369.5) (335.9) (312.2) (291.4)
Accumulated Other Comprehensive Income 0.1 (0.4) (0.2) (0.2) (0.2) (0.1) (0.0) (0.1) (0.1) (0.4)
Total Stockholders' Equity 473.1 228.6 137.2 187.4 67.9 103.9 54.6 (4.8) (168.7) 38.8
Total Liabilities & Equity 1,068.4 804.1 706.0 277.1 134.9 152.0 105.3 42.2 37.0 58.1
Debt Metrics
Total Debt 469.7 518.3 515.9 67.6 43.8 34.7 34.1 33.7 8.7 8.4
Net Debt (18.7) 181.6 121.1 (133.6) 18.2 10.1 14.1 13.4 (3.3) (1.4)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Operating Activities
Net Income 190.3 35.5 (25.0) (36.2) (44.2) (28.7) (33.5) (23.8) (20.8) (24.1)
Depreciation & Amortization 27.2 19.8 8.2 3.5 1.8 1.6 1.2 0.8 0.6 0.4
Stock-Based Compensation 36.9 33.2 19.8 10.3 6.9 2.4 0.9 0.1 0.1 0.0
Change in Working Capital 17.3 (45) (44.3) (26.8) 3.0 (5.6) (1.6) (4.3) (2.8) (0.9)
Other Non-Cash Items 4.8 5.4 30.0 3.4 3.7 0.5 0.5 0.2 0.1 0.1
Operating Cash Flow 192.8 48.8 (13.0) (45.8) (28.9) (30.3) (32.3) (26.0) (23.1) (24.1)
Investing Activities
Capital Expenditure (59.3) (129.7) (179.1) (11.9) (3.5) (0.5) (0.2) (0.4) (0.3) (1.5)
Acquisitions 0 0.4 (14.9) 0.1 0 41.1 60.3 0 0 0
Purchases of Investments 0 0 0 (10.5) (72.0) (121.8) (82.4) 0 (19.2) (46.5)
Sales/Maturities of Investments 0 0 0 76.9 104.8 80.7 22.0 12.7 44.3 8.3
Other Investing Activities 0 (129.7) (27.2) (0.1) 0 (41.1) (60.3) 12.7 25.1 (38.2)
Investing Cash Flow (59.3) (129.3) (194.0) 54.5 29.3 (41.6) (60.5) 12.3 24.9 (39.7)
Financing Activities
Net Debt Issuance 0 0 445.4 22.5 0 0 0 24.4 0 0
Stock Repurchased (0.1) 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 17.0 0 (45.0) 5.6 1.4 0.6 (4.6) (2.3) 0.0 (0.1)
Financing Cash Flow 16.9 22.9 400.4 167.9 1.4 75.5 92.7 22.1 0.0 63.5
Cash Position
Net Change in Cash 151.7 (58.2) 193.6 175.6 1.0 4.5 (0.1) 8.3 2.1 (0.2)
Cash at Beginning 337.1 395.3 201.7 26.1 25.1 20.6 20.7 12.4 10.3 10.6
Cash at End 488.9 337.1 395.3 201.7 26.1 25.1 20.6 20.7 12.4 10.3
Free Cash Flow 133.6 (80.9) (192.1) (57.7) (32.4) (30.7) (32.5) (26.4) (23.4) (25.6)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Income Statement
Revenue 605.5 441.5 241.6 93.5 30.3 25.6 23.6 13.0 7.7 6.2
Gross Profit 362.8 262.1 154.1 65.3 21.2 16.6 13.9 5.7 2.1 0.8
Operating Income 108.6 37.5 (28.7) (31.4) (39.4) (26.4) (29.6) (20.2) (20.4) (23.0)
Net Income 190.3 35.5 (25.0) (36.2) (44.2) (28.7) (33.5) (23.8) (20.8) (24.1)
EPS (Diluted) 4.87 1.01 -0.77 -1.23 -1.60 -1.16 -2.36 -1.23 -1.44 -1.66
Balance Sheet
Cash & Equivalents 488.4 336.6 394.8 201.2 25.6 24.6 20.1 20.2 11.9 9.8
Total Assets 1,068.4 804.1 706.0 277.1 134.9 152.0 105.3 42.2 37.0 58.1
Total Debt 469.7 518.3 515.9 67.6 43.8 34.7 34.1 33.7 8.7 8.4
Stockholders' Equity 473.1 228.6 137.2 187.4 67.9 103.9 54.6 (4.8) (168.7) 38.8
Cash Flow
Operating Cash Flow 192.8 48.8 (13.0) (45.8) (28.9) (30.3) (32.3) (26.0) (23.1) (24.1)
Capital Expenditure (59.3) (129.7) (179.1) (11.9) (3.5) (0.5) (0.2) (0.4) (0.3) (1.5)
Free Cash Flow 133.6 (80.9) (192.1) (57.7) (32.4) (30.7) (32.5) (26.4) (23.4) (25.6)